Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Change in Inventory: 2023-2024

Historic Change in Inventory for Iovance Biotherapeutics (IOVA) over the last 2 years, with Dec 2024 value amounting to $39.9 million.

  • Iovance Biotherapeutics' Change in Inventory fell 67.73% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.7 million, marking a year-over-year decrease of 6.47%. This contributed to the annual value of $39.9 million for FY2024, which is 294.51% up from last year.
  • As of FY2024, Iovance Biotherapeutics' Change in Inventory stood at $39.9 million, which was up 294.51% from $10.1 million recorded in FY2023.
  • Iovance Biotherapeutics' 5-year Change in Inventory high stood at $39.9 million for FY2024, and its period low was $10.1 million during FY2023.
  • Moreover, its 2-year median value for Change in Inventory was $25.0 million (2023), whereas its average is $25.0 million.
  • Data for Iovance Biotherapeutics' Change in Inventory shows a peak YoY spiked of 294.51% (in 2024) over the last 5 years.
  • Iovance Biotherapeutics' Change in Inventory (Yearly) stood at $10.1 million in 2023, then soared by 294.51% to $39.9 million in 2024.